68Ga-PSMA Positron Emission Tomography/Computed Tomography Provides Accurate Staging of Lymph Node Regions Prior to Lymph Node Dissection in Patients with Prostate Cancer.
about
Updates of prostate cancer staging: Prostate-specific membrane antigenDiagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients.Preliminary experience with dosimetry, response and patient reported outcome after 177Lu-PSMA-617 therapy for metastatic castration-resistant prostate cancerPSMA-PET/CT-Positive Paget Disease in a Patient with Newly Diagnosed Prostate Cancer: Imaging and Bone Biopsy FindingsProstate Specific Membrane Antigen Targeted 18F-DCFPyL Positron Emission Tomography/Computerized Tomography for the Preoperative Staging of High Risk Prostate Cancer: Results of a Prospective, Phase II, Single Center Study.The accuracy of 68Ga-PSMA PET/CT in primary lymph node staging in high-risk prostate cancer.(68)Ga-PSMA-11 PET/CT: the rising star of nuclear medicine in prostate cancer imaging?PET imaging for lymph node dissection in prostate cancer.PSMA PET and Radionuclide Therapy in Prostate Cancer.Metal-Based PSMA Radioligands.Diagnostic Accuracy of Ga-68-HBED-CC-PSMA-Ligand-PET/CT before Salvage Lymph Node Dissection for Recurrent Prostate Cancer.68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0.Comparison of 68Ga-PSMA-11 PET-CT with mpMRI for preoperative lymph node staging in patients with intermediate to high-risk prostate cancer.Detection level and pattern of positive lesions using PSMA PET/CT for staging prior to radiation therapy.Integration of CT urography improves diagnostic confidence of 68Ga-PSMA-11 PET/CT in prostate cancer patients.Salvage lymph node dissection after 68Ga-PSMA or 18F-FEC PET/CT for nodal recurrence in prostate cancer patients.Current status of theranostics in prostate cancer.99m Tc-MIP-1404-SPECT/CT for the detection of PSMA-positive lesions in 225 patients with biochemical recurrence of prostate cancer.Molecular imaging and fusion targeted biopsy of the prostate.68Ga-prostate specific membrane antigen (PSMA) positron emission tomography (PET) for primary staging of high-risk prostate cancer: a systematic review.Oligometastases in prostate cancer : Metabolic response in follow-up PSMA-PET-CTs after hypofractionated IGRT.68Ga-PSMA-11 PET/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour.[The role of PSMA PET-CT in patients with metastatic prostate cancer].Advances in prostate-specific membrane antigen PET of prostate cancer.The use of PET/CT in prostate cancer.[The role of PSMA PET-CT in patients with metastatic prostate cancer].Review of Gallium-68 PSMA PET/CT Imaging in the Management of Prostate Cancer.Prostate Imaging-Reporting and Data System Version 2: Beyond Prostate Cancer Detection.[When is surgical treatment indicated in metastatic prostate cancer and what is the scientific rationale?]MRI and 11C Acetate PET/CT for Prediction of Regional Lymph Node Metastasis in Newly Diagnosed Prostate Cancer.PSMA Theranostics: Current Status and Future Directions.PSMA-PET based radiotherapy: a review of initial experiences, survey on current practice and future perspectives.Prostate-Specific Membrane Antigen PET Imaging in Prostate Cancer: Opportunities and ChallengesComparison of 68Ga-labelled PSMA-11 and 11C-choline in the detection of prostate cancer metastases by PET/CTDifference in Frequency and Distribution of Nodal Metastases Between Intermediate and High Risk Prostate Cancer Patients: Results of a Superextended Pelvic Lymph Node DissectionKeeping up with the prostate-specific membrane antigens (PSMAs): an introduction to a new class of positron emission tomography (PET) imaging agentsClinical implications of PET/CT in prostate cancer management
P2860
Q28079444-00350224-BDA4-419F-8155-939997A01B0AQ33841484-4E6DC2A5-F54D-4A00-BB0C-8CBBD618A6BFQ37709519-4DFAE6AD-2C61-4B15-973A-B376A6EA5A29Q37726312-8C33CEB0-65EA-4856-944D-AFE670B54101Q38665724-013048C4-6D50-4B42-A9E2-C79589A1051DQ38720852-44BD19DE-CF14-4592-ACDE-AD36CBDD635AQ38747415-C29EF8AA-C1EB-4237-A65C-906962746D4AQ38983526-F8F1AA2E-A38E-4FF7-86C6-6AF9BD14FDDBQ39003089-9548CCC7-B8E6-48DB-AB13-58D1EDC99180Q39198527-0569910E-7C18-40AA-A90C-1DB7EFF26C97Q42257970-127E95FC-B328-49E0-98FB-BBFCE462F76DQ46225464-D8D7006C-2A54-4A9C-A31B-163B5D9158C1Q47097602-4E6991DA-0376-4888-8B69-D4F9E3C47D47Q47107456-45136010-9E21-4EBA-BEE2-F00216C28BE6Q47109640-FF7A7C21-1845-4C39-8F58-42B51C1EB01DQ47115390-7C0F1404-45C5-4B9C-A23F-D033C42F45A1Q47241139-8DE06E79-1291-4CB6-BAFE-CA7D3576B670Q47438555-505FA588-A0D9-41C0-BF26-1107BB4CC105Q47608215-D03C268B-D931-4DEB-B1E7-2122833F2D91Q48222301-1454712C-5B6D-4318-9514-98D55B803D2DQ48226517-1F5E9A43-493E-45D9-91A2-448E6B7CE2C5Q48295687-FE475785-1CE1-4CE2-B9A1-B8CCB1BF73B9Q49589359-D05A2876-B7A7-447F-8E52-E8593BA1766AQ49713199-A608F1D7-2978-4675-9110-F8FE296B1F5EQ49919217-FABB4D92-6A93-492E-98E3-13B459AF6906Q49981290-87D99DC4-D481-4AE9-AE9D-E0457ADC7BE2Q50034009-00AB8E78-20F5-4D98-AA4C-61EB0D6D09F7Q52665654-E8D28091-68D9-4186-B993-F264C6DC8B47Q52889384-7C5E074E-E9F6-464E-A5E2-7C3F4B78ECF1Q55000240-63D1F293-8A34-496F-B379-29319CF53112Q55023828-D034D98D-37F1-4FC1-B828-25425903EA95Q55399763-E2A68CF8-57D3-4586-916C-A2AC615671ABQ57107208-BFB5369D-9924-420E-9E26-79AFB98E1BE8Q57661498-A6774939-2266-4E2C-B4E2-A5F50306DDE2Q58758865-AC4E0FDE-1784-43EB-A02C-FE841AEB74DFQ59130960-E3E23BDD-A053-44BE-BAFF-316E18269888Q59137133-49ECD7EF-D980-4EF3-8C71-69472A9B2C55
P2860
68Ga-PSMA Positron Emission Tomography/Computed Tomography Provides Accurate Staging of Lymph Node Regions Prior to Lymph Node Dissection in Patients with Prostate Cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
68Ga-PSMA Positron Emission To ...... Patients with Prostate Cancer.
@en
68Ga-PSMA Positron Emission To ...... Patients with Prostate Cancer.
@nl
type
label
68Ga-PSMA Positron Emission To ...... Patients with Prostate Cancer.
@en
68Ga-PSMA Positron Emission To ...... Patients with Prostate Cancer.
@nl
prefLabel
68Ga-PSMA Positron Emission To ...... Patients with Prostate Cancer.
@en
68Ga-PSMA Positron Emission To ...... Patients with Prostate Cancer.
@nl
P2093
P1433
P1476
68Ga-PSMA Positron Emission To ...... Patients with Prostate Cancer.
@en
P2093
Alexander Kretschmer
Annika Herlemann
Christian Gratzke
Claudius Faber
Franz-Josef Gildehaus
Kolja M Thierfelder
Peter Bartenstein
Vera Wenter
Wolfgang P Fendler
P304
P356
10.1016/J.EURURO.2015.12.051
P407
P577
2016-01-19T00:00:00Z